PRAMEF13 Gene

Name PRAME family member 13
Description Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul2-RING ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have highlighted that NEK9, a member of the NIMA‐related kinase family, plays a pivotal role as an adaptor protein facilitating autophagy‐dependent primary cilia formation. In one investigation, NEK9 was shown to interact with GABARAPs via its LC3-interacting region (LIR) and with the actin regulator MYH9. This interaction is crucial for the proper degradation of MYH9 during ciliogenesis, and mutations in the LIR impair the formation of primary cilia, a modification that appears to have evolved in land vertebrates."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n \nAnother study connected NEK9 with the replication stress response. Here, NEK9 was identified as a critical factor for maintaining genome integrity under replication stress conditions. Its depletion led to hypersensitivity to replication blocks, spontaneous DNA damage, and impaired CHK1 activation—underscoring NEK9’s importance in coordinating DNA repair and cell cycle checkpoint signaling in response to replication challenges."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n \nComplementary research further expanded the functional repertoire of NEK9 by demonstrating its central role in cell division. NEK9 is essential for proper spindle formation and chromosome alignment during both mitosis and meiosis. In mouse oocytes and early embryos, its depletion resulted in defective spindle organization, misaligned chromosomes, and cell cycle arrest, pointing to a function in microtubule nucleation at the spindle-organizing centers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Additionally, NEK9, together with NEK2, contributes to endothelial barrier regulation; inhibition of these kinases alleviated lipopolysaccharide-induced hyperpermeability and myosin light chain 2 activation, highlighting a potential therapeutic target in severe lung injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yasuhiro Yamamoto, Haruka Chino, Satoshi Tsukamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NEK9 regulates primary cilia formation by acting as a selective autophagy adaptor for MYH9/myosin IIA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-23599-7"}], "href": "https://doi.org/10.1038/s41467-021-23599-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34078910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34078910"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Scott C Smith, Aleksandra V Petrova, Matthew Z Madden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gku840"}], "href": "https://doi.org/10.1093/nar/gku840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25217585"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25217585"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shang-Wu Yang, Chen Gao, Lei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nek9 regulates spindle organization and cell cycle progression during mouse oocyte meiosis and its location in early embryo mitosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.22690"}], "href": "https://doi.org/10.4161/cc.22690"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23159858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23159858"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nektarios Barabutis, Mohammad S Akhter "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Microvasc Res (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mvr.2023.104651"}], "href": "https://doi.org/10.1016/j.mvr.2023.104651"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38176677"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38176677"}]}]}]}
NCBI Gene ID 400736
API
Download Associations
Predicted Functions View PRAMEF13's ARCHS4 Predicted Functions.
Co-expressed Genes View PRAMEF13's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View PRAMEF13's ARCHS4 Predicted Functions.

Functional Associations

PRAMEF13 has 359 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.

Click the + buttons to view associations for PRAMEF13 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of PRAMEF13 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing PRAMEF13 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with PRAMEF13 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with PRAMEF13 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Biological Process Annotations 2025 biological processes involving PRAMEF13 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing PRAMEF13 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by PRAMEF13 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of PRAMEF13 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of PRAMEF13 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of PRAMEF13 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of PRAMEF13 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of PRAMEF13 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of PRAMEF13 gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with PRAMEF13 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.